Direct renin inhibitor: Aliskiren in chronic kidney disease

6Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

The renin-angiotensin-aldosterone system (RAAS) plays pivotal roles in the pathogenesis of chronic kidney disease (CKD) progression and its increased complications such as hypertension (HT) and cardiovascular diseases (CVD). Previous studies suggested that aliskiren a direct renin inhibitor, blocks RAAS and may be effective for the management of CKD and its complications. This review focuses on the effects of aliskiren on CKD. © 2013, Kowsar Corp.; Published by Kowsar Corp.

Cite

CITATION STYLE

APA

Morishita, Y., & Kusano, E. (2013). Direct renin inhibitor: Aliskiren in chronic kidney disease. Nephro-Urology Monthly. Brieflands. https://doi.org/10.5812/numonthly.3679

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free